Florence, Italy - 13 May 2016: Myocardial fibrosis could be a future therapeutic target after researchers found it correlated with adverse cardiovascular outcomes in patients with obstructive ...

Citation information: Myocardial Fibrosis in the Pathogenesis, Diagnosis, and Treatment of Hypertrophic Cardiomyopathy, Zeyi Cheng, Miaomiao Qi, Chengyuan Zhang and Yanxia Mao, Cardiovasc.

Key Results. Change in myocardial ECV from baseline to week 52 was positively correlated with change in left ventricular end diastolic volume, indexed for body surface area (r, 0.23; P = .039) and ...

To the Editor: Ho and colleagues (Aug. 5 issue)1 report that an elevated level of serum C-terminal propeptide of type I collagen (PICP) may be interpreted as a biomarker of myocardial fibrosis in ...

Myocardial fibrosis is an important prognostic marker in the development of adverse cardiovascular events, such as heart failure and death. Skip to content. Menu. Medical Home Life Sciences Home.

For patients with dilated cardiomyopathy, myocardial fibrosis independently predicts all-cause mortality; and for patients with coronary artery disease and regional wall thinning, ...

WASHINGTON — Among patients with asymptomatic severe aortic stenosis and myocardial fibrosis, transcatheter or surgical aortic valve replacement did not improve outcomes compared with guideline ...

Is myocardial fibrosis in HCM the product of longstanding disease, or can it emerge early in the process, perhaps even as a cause of the other characteristic structural changes?

Fibrosis is an established morphological feature of the structural myocardial remodeling that occurs in several cardiac diseases. This feature confers an increased risk for adverse cardiovascular ...

Cardiac MRI findings indicated myocardial inflammation and fibrosis were associated with rheumatoid arthritis disease activity, according to published results.Researchers studied 60 patients with ...